Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan;22(1):62-7.
doi: 10.1007/s11606-007-0118-3.

Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma

Todd A Lee  1 , Frances M Weaver, Kevin B Weiss
Affiliations

Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma

Todd A Lee et al. J Gen Intern Med. 2007 Jan.

Abstract

Background: Patients with chronic obstructive pulmonary disease (COPD) are included in several national pneumococcal vaccination recommendations whereas asthma patients are not. The objective of this study was to evaluate pneumonia-related hospitalization risk in patients with COPD or asthma and vaccination impact.

Methods: We identified patients with documented pneumococcal vaccination from a cohort of veterans with either a diagnosis of asthma or COPD and their matched controls. Patients were identified between October 1, 1997 and September 30, 1998 and followed for 5 years. For each group we identified pneumococcal pneumonia hospitalizations and all pneumonia-related hospitalizations in the periods before and after vaccination. We estimated hospitalization rates and compared rates in the asthma and COPD groups to controls using negative binomial regression models.

Results: We identified 16,074 COPD patients (average age 65.8 years), 14,028 controls for the COPD patients (average age 67.5 years), 2,746 asthma patients (average age 53.0 years), and 1,345 controls for the asthma patients (average age 59.2 years). Compared to controls, the adjusted risk of pneumococcal pneumonia hospitalizations before pneumococcal vaccination was COPD = 8.02 (95% CI, 4.44-14.48) and asthma = 0.76 (0.17-3.53). For any pneumonia-related hospitalization, the adjusted risk was COPD = 3.91 (3.40-4.50) and asthma = 1.45 (0.85-2.46). After vaccination, events decreased in all groups. The adjusted risk for pneumococcal pneumonia hospitalizations postvaccination was COPD = 3.87 (2.55-5.88) and asthma = 0.30 (0.04-1.99). For any pneumonia-related hospitalization the adjusted risk was COPD = 3.71 (3.33-4.13) and asthma = 0.79 (0.50-1.25).

Conclusions: This study supports the value of vaccinating COPD patients; however, the value of vaccination for asthma patients is less certain.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cohort identification process for patients included in the analysis.
See this image and copyright information in PMC

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.272.14.1133', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.272.14.1133'}, {'type': 'PubMed', 'value': '7933327', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7933327/'}]}
    2. Fedson DS. Adult immunization. Summary of the National Vaccine Advisory Committee Report. JAMA. 1994;272:1133–37. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9132580', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9132580/'}]}
    2. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1997;46:1–24. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '7616952', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7616952/'}]}
    2. Centers for Disease Control and Prevention. Assessing adult vaccination status at age 50 years. MMWR. 1995;44:561–63. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9776166', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9776166/'}]}
    2. Centers for Disease Control and Prevention. Pneumococcal and influenza vaccination levels among adults aged ≥65 years—United States, 1997. MMWR. 1998;47:797–802. - PubMed
    1. Sheikh A, Alves B, Dhami S. Pneumococcal vaccine for asthma. Cochrane Database Syst Rev. 2002;CD002165. - PubMed

Publication types

Substances